Russia-developed COVID-19 drug to start production in December- Firm to Sputnik

Nov 13, 2021

Moscow [Russia], November 13 (ANI/Sputnik): The production of the Favipiravir antiviral drug that will be used in COVID-19 vaccines will commence in December, the...

Anti-viral drug Favipiravir shows clinical improvement in mild, moderate COVID-19 cases: Glenmark

Jun 20, 2020

New Delhi [India], June 20 : Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of...

Covid-19: Indore ramps up manufacturing of Favipiravir amid predictions of third wave

May 28, 2021

Indore (Madhya Pradesh) [India], May 28 : Owing to the prediction of the third wave of Covid-19, the manufacturer of Favipiravir medicine (an antiviral...

Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderate COVID-19 infections

Jun 22, 2020

Mumbai (Maharashtra) [India], June 22 : Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became...

'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir, Favipiravir in fighting COVID-19'

May 15, 2020

New Delhi [India], May 15 : The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the...

Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India

May 12, 2020

Mumbai (Maharashtra) [India], May 12 : Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first...